Sinufrin Decongestant Solution
NDC Package 13709-355-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Sinufrin Decongestant (nasal congestion relief) solution is adults and children 6 to 12 years of age (with adult supervision): Per dose, 2 sprays in each nostril not more often than every 10 to 12 hours. This formulation utilizes a solution delivery system. Marketed by Neilmed Pharmaceuticals Inc, this product is identified by NDC 13709-355 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
13709-355-01
Package Description
1 BOTTLE in 1 CARTON / 15 mL in 1 BOTTLE
Product Code
13709-355
11-Digit Billing Format
13709035501
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Sinufrin Decongestant
Non-Proprietary Name
Nasal Congestion Relief
Substance Name
Oxymetazoline Hydrochloride
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Nasal - Administration to the nose; administered by way of the nose.
Active Ingredient(s)
OXYMETAZOLINE HYDROCHLORIDE 7.5 mg/15mL
Pharmacologic Class
Usage Information
Adults and children 6 to 12 years of age (with adult supervision): Per dose, 2 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period. Children under 6 years of age: consult a doctor n To use: To spray, squeeze bottle quickly and firmly. Keep head upright and do not tilt head backward while spraying. Wipe nozzle clean after use. Secure cap after use.

Regulatory & Marketing

Labeler Name
Neilmed Pharmaceuticals Inc
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-25-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 13709-355-01 identifies a specific commercial package of 1 bottle in 1 carton / 15 ml in 1 bottle of Sinufrin Decongestant, a human over the counter drug labeled by Neilmed Pharmaceuticals Inc. This solution is formulated for nasal use and contains oxymetazoline hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Neilmed Pharmaceuticals Inc on May 25, 2026. The current certification is valid through December 31, 2027.

How is this Neilmed Pharmaceuticals Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 13709035501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
13709-355-01
11-Digit CMS (5-4-2)
13709-0355-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.